We advise that specialist opinion is sought when the patient has a diagnosed heart condition, and provide the following information to guide clinicians in their judgement.
There have been no adverse events reported to Firstkind or in the literature (there are over 70 published papers) concerning heart conditions and geko® devices. We do have unpublished data on file concerning clinical studies that we have run that included patients with a range of cardio-vascular comorbidities (including atrial fibrillation and hypertension) and no adverse events have been reported that were related to these conditions.
The geko® device is not a form of external compression therapy, it works by stimulating the common peroneal nerve activating the calf and foot muscle pumps, resulting in increased venous, arterial and microcirculatory blood flow in the lower limb to which it has been fitted.
The blood flow stimulated by the geko® device equals 60% of that of walking. If a patient has a heart condition but is allowed to walk around then the geko® device is not expected to deleteriously affect the patient’s condition.